Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Arjo Annual Report 2020 – Mobility drives improved outcomes in healthcare

Today Arjo publishes the Annual Report for 2020. A success factor during the year was that Arjo navigated the short-term challenges in connection with the pandemic while capitalizing on new business opportunities and investing in the future. In 2020, Arjo also presented a new strategy for 2030 as well as a new sustainability framework. “We put an exceptional year behind us, where we have adapted the business to the current circumstances and supported healthcare in a challenging time. At the same time, we exceeded the targets that we set at the beginning of the year. Three years have

ABB shareholders approve all proposals at 2021 Annual General Meeting

Zurich, Switzerland, March 25, 2021 - Payout of dividend and Board and Executive Committee compensation confirmed. Shareholders also approved capital reduction through the cancellation of shares repurchased under ABB’s share buyback program.The shareholders of ABB have approved all the proposals by the company’s Board of Directors at its 2021 Annual General Meeting. Due to the extraordinary circumstances and in line with applicable Swiss COVID-19 legislation, shareholders were not able to attend the meeting in person but could exercise their shareholder rights via the independent proxy who

Change in the holding of Kesko Corporation's treasury shares

Kesko Corporation has today transferred a total of 19,962 of its own B shares (KESKOB) held by the Company as treasury shares to members of management and other selected key persons who were included in the target group for the PSP 2019-2022 share-based commitment and incentive plan in the 2019 and 2020 performance periods, and to selected key persons in accordance with the terms and conditions of the RSP 2018-2020 plan. The transfer of the shares is based on a decision by Kesko's Board of Directors, announced in a stock exchange release on 3 February 2021, to grant own B shares held by

Azelio is selected to present its energy storage at the 2021 NREL Industry Growth Forum

As one of 40 emerging cleantech companies selected globally, Azelio will present its energy storage solution TES.POD to investors and other cleantech industry stakeholders at the 2021 NREL Industry Growth Forum.Azelio has been selected to present its TES.POD to investors and industry representatives at the 2021 NREL Industry Growth Forum (IGF), to be held virtually on April 20-22, 2021. The IGF, celebrating its 26th anniversary, is hosted by the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL). It is one of the nation’s premier events for cleantech entrepreneurs and

UPM Timber has completed employee consultation process

(UPM, Helsinki, 25 March 2021 at 11:30 EET) – UPM Timber has completed the employee consultation process started in early February on its plans to improve profitability and strengthen competitiveness. Based on the negotiations, the number of positions at UPM Timber will decrease by 43. As a result of the negotiations, UPM Timber is renewing the management model of its sawmills and streamlining its supply chain. In addition, the small log line at Kaukas sawmill will be closed by the end of June 2021 and the operating model of Korkeakoski sawmill will be optimized. UPM provides support

Four Instalco companies collaborate on assignment for Peab

Four Instalco companies have been contracted by Peab Sverige AB for a joint assignment in Malmö. The work involves design and installation of the electrical, heating & plumbing, ventilation and sprinkler systems in conjunction with construction of Oatly’s new head office at the property called Gjuteriet in Malmö.The estimated order value for the assignment is approximately SEK 45 million and it will be run as a partnering project together with Peab and Varvstaden AB. The Instalco companies that will jointly participate in the project are: Insta EL (electrical), Rörläggaren (heating &

Opterion Health AG appoints Björn Englund as CEO

· Opterion Health AG has appointed Björn Englund as CEO, starting in April 2021 · Björn Englund will take over from the founder of Opterion, Guido Grentzmann, who will focus on his role as Chief Scientific Officer (CSO) · Preparation for Phase I at full speed, following the successful Bridge Financing Roundof EUR 8.4m · The relocation of the company to Muttenz (BL) is to be officially conducted in April 2021Sarnen, Switzerland, 25 March 2021 – Opterion Health AG, a preclinical Swiss life science company, developing the first novel solution for peritoneal dialysis (PD) in the last

Beijer Ref and Bitzer extend their partnership

Beijer Ref and Bitzer are among the leaders in the refrigeration and air conditioning industry and confirms their successful collaboration once again and extend their partnership agreement for another three years.The contract covers more than 430 Beijer Ref branches in over 35 markets in Europe, Asia-Pacific and Africa. Per Bertland, CEO Beijer Ref, comments: “We have long experience of working with Bitzer and they have a very developed product portfolio that is important for Beijer Ref. They are also in the forefront when it comes to providing high technology solutions based on

Volati’s Nomination Committee’s proposals for AGM 2021

The Nomination Committee of Volati AB (publ) has decided to propose re-election of Board members Anna-Karin Celsing, Björn Garat, Louise Nicolin, Karl Perlhagen, Magnus Sundström, Christina Tillman and Patrik Wahlén. The Committee also proposes the re-election of Patrik Wahlén as Chairman of the Board and the re-election of Ernst & Young Aktiebolag as auditor until the end of the next annual general meeting. Information about the Board members proposed for re-election can be found on Volati’s website, www.volati.se. The Nomination Committee consists of Carin Wahlén (chair,

Finnair shows green light to electric flying, signs letter of interest on electric aircraft developed by Heart Aerospace

Finnair has signalled its interest for electric aviation as a force to be reckoned with for future flying, signing a Letter of Interest for Heart Aerospace's Electric ES-19 electric aircraft, which is currently under development.    Finnair could acquire up to 20 of the new 19-seater Heart Aerospace ES-19 electric aircraft, for use on the airline’s short routes. According to Heart Aerospace, the aircraft are expected to be available for first commercial flights in 2026.   Anne Larilahti, Finnair Vice President of Sustainability, said: “Finnair believes electric aviation will be one of

I.A.R. Systems Group AB Annual Report 2020

The Board of Directors and the CEO of I.A.R. Systems Group AB hereby present the annual report for I.A.R. Systems Group AB and the I.A.R. Systems Group for the financial year 2020. If you would like to receive the annual report in printed form, please send an email to josefin.skarin@iar.com. This information is information that I.A.R. Systems Group is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 10:00 CET on 2021-03-25.

Cederquist advises on the IPO of the first SPAC in Sweden

Cederquist is legal advisor to ACQ Bure AB (publ), a Swedish acquisition company, so-called SPAC (Special Purpose Acquisition Company), in connection with its initial public offering and listing on Nasdaq Stockholm, raising approx. SEK 3.5 billion. ACQ Bure AB has been established on the initiative of the investment company Bure Equity AB and is the first SPAC in Sweden. The listing is conducted under the new rules of Nasdaq Stockholm for SPACs, which entered into force on 1 February. SPACs are a phenomenon which have become increasingly common in the US. The SPAC raises capital and is

BioStock Studio: Gabather gives clinical trial update

Gabather’s top candidate GT-002 for treating psychiatric or mood disorders like depression, anxiety, and schizophrenia is currently in the early stages of clinical development. The company is planning a key target engagement study in healthy volunteers aimed at showing how GT-002 modulates brain activity at both the functional and regional levels of the brain. The company's CEO Michael-Robin Witt joined BioStock via link to tell us more about GT-002 and give us an update on the ongoing clinical trial.Watch the interview with Gabather's CEO Michael-Robin Witt at biostock.se:  https://www.

Annual report for 2020 is published today

SpareBank 1 SR-Banks annual report for 2020 and Pillar III-report for 2020 are published today, on the group’s website www.sr-bank.no under “Investor Relations”.Contact people:Inge Reinertsen, CFO, Tel. +47 909 95 033 Stian Helgøy, Vice President Investor Relations, Tel. +47 906 52 173 Thor-Christian Haugland, Executive Vice President Communications, Tel. +47 480 31 633 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Shawbrook Bank Recognised Twice in MoneyComms ‘Top Performers 2021’ List

· The specialist bank has been named ‘Best Personal Loans Provider’ and ‘Best Business Savings Provider of the Year’ · MoneyComms, now in its 9[th] year, monitors and analyses personal and business finance products, rates and trends across a range of industriesLONDON: 25/03/21 Shawbrook Bank has been recognised twice in the latest ‘Top Performers’ list by MoneyComms. The specialist bank – which serves UK-based consumers and businesses – has been named ‘Best Personal Loan Provider’ and ‘Best Business Savings Provider’ of the year. Shawbrook’s products were assessed against its

TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development

Veeva Vault unifies clinical documents and processes to improve collaboration and speed execution Veeva Systems  (NYSE: VEEV) today announced that TFS HealthScience will be the first CRO to have selected Veeva Vault Clinical Operations Suite  for end-to-end study management on a single cloud platform. The European-headquartered global CRO is taking action to further modernize the study operations, adopting the entire suite to drive greater efficiency and speed in trials. TFS HealthScience will now be

Outokumpu to develop its supplier monitoring and transparency in sourcing

Outokumpu OyjPress releaseMarch 25, 2021 at 10.15Outokumpu to develop its supplier monitoring and transparency in sourcing Outokumpu is taking actions to further develop the monitoring of its suppliers and to increase the transparency of its sourcing. After the report of the Finnish NGO Finnwatch in February, the company has also decided to audit Vale, one of its ferronickel suppliers. ”The Finnwatch report was an important reminder of the importance of responsibility throughout Outokumpu’s supply chain. As the leading provider of sustainable stainless steel, we have set high

Vestas seals largest EnVentus order to date in Germany

News release from Vestas Northern and Central EuropeHamburg, 25 March 2021 Vestas has secured its largest EnVentus order yet in Germany, at the 39 MW Wohlsdorf project in Rotenburg, Lower Saxony. Vestas will supply seven V150-5.6 MW turbines to the project, which is located in between Bremen and Hamburg. The Wohlsdorf project is being developed by Windpark Wohlsdorf GmbH & Co. KG, a special purpose company owned by Reon and CapCerta. The project was awarded as part of the German Federal Network Agency’s (BNetzA) latest onshore wind auction rounds. The V150 EnVentus turbines in

YIT Announces Indicative Tender Offer Results for its outstanding notes due 2021 and 2023

YIT Corporation    Stock Exchange Release    25 March 2021 at 10:00 a.m.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NEW NOTES, OR THE CAPITAL SECURITIES, THE TENDER OFFER OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. YIT Announces Indicative Tender Offer Results for its outstanding notes due 2021 and 2023 YIT Corporation announces

Swedish tech success Regily launches Checkin.com

Tech success Regily was founded in Sweden four years ago, by former product frontmen of Klarna, with the idea of replacing the existing and often complicated online processes for signup and identification with one unified process for user onboarding, or checkin. The company has since then developed their unique SaaS offering to become the world’s leading checkin-solution, guaranteeing their partners increased conversion irrespective of the end-users  geography or device. Regily now releases the third generation software with the launch of Checkin.com.The company's unique SaaS-offering makes

Annual report 2020

Beijer Ref´s Annual Report for 2020 is now available on www.beijerref.com. The printed version will be available in April. Malmö, 25 March 2021 Beijer Ref AB (publ) For further information, please contact: Per Bertland, CEO Telephone +46 40-35 89 00 Email pbd@beijerref.com Maria Rydén, CFO Telephone +46 40-35 89 00 Email mrn@beijerref.com BEIJER REF AB is a technology-oriented trading Group which, through added-value products, offers its customers competitive solutions within refrigeration and climate control. Beijer Ref is one of the largest refrigeration

Exercise of Options

Faron Pharmaceuticals Oy (“Faron” or the “Company”) Exercise of options Issue of equity Company announcement, 25 March 2020 at 9.45 AM (EET)   TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces that it has received a notification from Toni Hänninen, Faron’s CFO, to exercise D options over 40,000 ordinary shares in the Company at an exercise price of EUR 1.09 (approx. GBP 0.94) per share under the Company’s 2015 Option Plan (“New Ordinary Shares”). The terms and conditions of the 2015 Option

IRLAB’s drug candidate mesdopetam's mechanism of action receives confirmation by independent scientists

IRLAB (Nasdaq Stockholm: IRLAB A) announced today that independent scientists have confirmed that the dopamine D3 receptor (D3R) is a highly promising drug target with therapeutic potential in levodopa-induced dyskinesia, especially when the receptor’s unique signaling properties are taken into account. IRLAB’s mesdopetam is currently the most advanced D3R antagonist compound in the global neurology pipeline. It is used in the scientific article to exemplify a compound that could have an impact on the management of anumber of disorders marked by aberrant D3R activity. The article was

There are no items matching the current filter
There are no more items matching the current filter
Back to top